On this page you can find:

• Who is at risk for overweight and obesity?
• What surveillance modality should be used and at what frequency should it be performed?
• What should be done if abnormalities are identified?

Who is at risk for overweight and obesity?

CAYA cancer survivors

• with a hypothalamic or pituitary tumour
• treated with radiotherapy to a volume exposing the hypothalamus or pituitary gland, including TBI
• treated with neurosurgery of the hypothalamus or pituitary gland

What surveillance modality should be used and at what frequency should it be performed?

• Height, weight and BMI
  at least every 2 years and at every long-term follow-up visit

What should be done if abnormalities are identified?

• Evaluate other features of metabolic syndrome (including dyslipidaemia, diabetes and hypertension)

• Refer to a dietician or refer for a combined lifestyle intervention for weight management
• Consider referral to the appropriate HCP for management of metabolic syndrome
• Consider referral to an endocrinologist for evaluation and management of central endocrinopathies

Disclaimer

While PanCare strives to provide accurate and complete information that is up-to-date as of the date of publication, we acknowledge that the sequence of referral and diagnostic tests might vary according to the local and national healthcare system logistics.

It is recognised that survivors and their healthcare professionals have the final responsibility for making decisions concerning their long-term follow-up care. As such, they may choose to either adopt these recommendations or not to do so after individual informed discussion. It is good practice to document this decision.

In addition to regular surveillance, real-time awareness and prompt reporting of new symptoms and signs is essential to the early detection and timely treatment of late effects.

No warranty or representation, expressed or implied, is made concerning the accuracy, reliability, completeness, relevance, or timeliness of this information.

The PanCare materials are free to use for anyone aiming to inform about late effects and long-term survivorship care. However, no financial advantage may be achieved. All communication should reference PanCare and link to the PanCare website.